Thông tin tài liệu
Nhan đề : | Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20) |
Tác giả : | Chen, Huei-Jen Cheng, Yi-An Chen, Yu-Tung |
Năm xuất bản : | 2023 |
Nhà xuất bản : | Springer |
Tóm tắt : | PEGylated nanoparticles (PEG-NPs) are not effective for hematologic malignancies as they lack the enhanced permeability and retention effect (EPR effect). Tumor-targeted PEG-NPs can systemically track lymphoma and actively internalize into cancer cells to enhance therapeutic efficacy. We generated an anti-PEG bispecific antibody (BsAb; mPEG × CD20) which was able to simultaneously bind to methoxy PEG on liposomes and CD20 to form multivalent αCD20-armed liposomes. This αCD20-armed liposome was able to crosslink CD20 on lymphoma cells to enhance cellular internalization and the anti-cancer efficacy of the liposomes to lymphoma. We generated mPEG × CD20 and used this bispecific antibody to modify PEGylated liposomal doxorubicin (PLD) through a one-step formulation. |
Mô tả: | CC-BY |
URI: | https://link.springer.com/article/10.1186/s12645-023-00230-6 https://dlib.phenikaa-uni.edu.vn/handle/PNK/9506 |
Bộ sưu tập | OER - Khoa học Vật liệu, Ứng dụng |
XEM MÔ TẢ
8
XEM TOÀN VĂN
0
Danh sách tệp tin đính kèm: